COVID-19 discharge and follow-up recommendations.
Anticoagulation
COVID-19 discharge recommendations
corticosteroid therapy
follow-up
oxygen therapy
Journal
Proceedings (Baylor University. Medical Center)
ISSN: 0899-8280
Titre abrégé: Proc (Bayl Univ Med Cent)
Pays: United States
ID NLM: 9302033
Informations de publication
Date de publication:
30 Oct 2020
30 Oct 2020
Historique:
entrez:
18
1
2021
pubmed:
19
1
2021
medline:
19
1
2021
Statut:
epublish
Résumé
Currently, the world is facing a global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19. So far, there are no clear recommendations regarding hospital discharge and aftercare for COVID-19. Here, we briefly discuss the current understanding of recommendations for discharge criteria, discharge treatment regimens, and follow-up.
Identifiants
pubmed: 33456149
doi: 10.1080/08998280.2020.1834341
pii: 1834341
pmc: PMC7785155
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
73-75Informations de copyright
Copyright © 2020 Baylor University Medical Center.
Références
TH Open. 2020 Mar 13;4(1):e59-e65
pubmed: 32190813
Respir Care. 2019 Mar;64(3):272-278
pubmed: 30401753
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
Bone Joint J. 2017 Nov;99-B(11):1420-1430
pubmed: 29092979
N Engl J Med. 2020 Jul 17;:
pubmed: 32678530